These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22825426)

  • 1. PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors.
    Li J; Zhang W; Duan MH; Jiao L; Zhu TN; Han B; Zhang L; Gan J; Zhou DB
    Bone Marrow Transplant; 2013 Feb; 48(2):233-7. PubMed ID: 22825426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma.
    Hiwase DK; Bollard G; Hiwase S; Bailey M; Muirhead J; Schwarer AP
    Cytotherapy; 2007; 9(6):539-47. PubMed ID: 17882718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen.
    Dawson MA; Schwarer AP; Muirhead JL; Bailey MJ; Bollard GM; Spencer A
    Bone Marrow Transplant; 2005 Sep; 36(5):389-96. PubMed ID: 15980882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Granulocyte Colony-Stimulating Factor Monotherapy for Peripheral Blood Stem Cell Collection in POEMS Syndrome.
    Muto T; Ohwada C; Takaishi K; Isshiki Y; Nagao Y; Hasegawa N; Kawajiri-Manako C; Togasaki E; Shimizu R; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Takeuchi M; Sakaida E; Misawa S; Shimizu N; Iseki T; Kuwabara S; Nakaseko C
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):361-363. PubMed ID: 27840209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation.
    Jimenez-Zepeda VH; Trudel S; Reece DE; Chen C; Rabea AM; Kukreti V
    Am J Hematol; 2011 Oct; 86(10):873-5. PubMed ID: 21815185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on high-dose etoposide with granulocyte colony-stimulating factor for mobilization of autologous peripheral blood stem cells in patients with hematologic malignancies].
    Shen WY; Li JY; Hong M; Zhang R; Lu H; Liu P; Qian SX; Xu W; Qiu HX; Wu HX
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):628-31. PubMed ID: 23134856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies.
    Hamadani M; Kochuparambil ST; Osman S; Cumpston A; Leadmon S; Bunner P; Watkins K; Morrison D; Speir E; Deremer D; Kota V; Jillella A; Craig M; Awan F
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1128-35. PubMed ID: 22248715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixafor.
    Shimizu N; Sakaida E; Ohwada C; Takeuchi M; Kawaguchi T; Tsukamoto S; Sakai S; Takeda Y; Sugita Y; Yokote K; Iseki T; Isose S; Kanai K; Misawa S; Kuwabara S; Nakaseko C
    Bone Marrow Transplant; 2012 Dec; 47(12):1587-8. PubMed ID: 22609884
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors associated with the efficiency of PBSC collection in POEMS syndrome patients undergoing autologous PBSC transplantation.
    Shimizu N; Nakaseko C; Sakaida E; Ohwada C; Takeuchi M; Kawaguchi T; Tsukamoto S; Sakai S; Takeda Y; Abe D; Yokote K; Iseki T; Kanai K; Misawa S; Kuwabara S
    Bone Marrow Transplant; 2012 Jul; 47(7):1010-2. PubMed ID: 22041850
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.
    Li J; Zhou DB; Huang Z; Jiao L; Duan MH; Zhang W; Zhao YQ; Shen T
    Ann Hematol; 2011 Jul; 90(7):819-26. PubMed ID: 21221584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator.
    Herbert KE; Morgan S; Prince HM; Westerman DA; Wolf MM; Carney DA; Yuen K; di Iulio J; Seymour JF
    Leukemia; 2009 Feb; 23(2):305-12. PubMed ID: 18987661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation.
    Dhédin N; Prébet T; De Latour RP; Katsahian S; Kuentz M; Piard N; Réa D; Norol F; Jouet JP; Ribeil JA; Tabrizi R; Rio B; Lioure B; Tiberghien P; Bourhis JH; Sirvent A; Bordigoni P; Blaise D; Michallet M; Vernant JP
    Bone Marrow Transplant; 2012 Dec; 47(12):1564-8. PubMed ID: 22609881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patients.
    Kolbe K; Peschel C; Rupilius B; Després D; Burger K; Sklenar I; Färber L; Huber C; Derigs HG
    Bone Marrow Transplant; 1997 Dec; 20(12):1027-32. PubMed ID: 9466274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.